Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 997.70
+76.45 (8.30%)
Nov 6, 2026, 3:29 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 20.59 billion as of November 6, 2026. It is the 19,842nd most valuable company in the world and the 1,231st biggest in India. Its market cap has increased by 4.75% in one year.
Market Cap
20.59B
Enterprise Value
18.50B
Revenue
9.93B
Global Rank
Country Rank
#1,231 India
PE Ratio
31.91
ChartMarket Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 20.59B, an increase of 132.02%. That is a compound annual growth rate of 17.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 20.52B | 23.15% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 42.93B |
| Solara Active Pharma Sciences | 31.04B |
| Ind-Swift Laboratories | 31.02B |
| Sakar Healthcare | 22.60B |
| Indoco Remedies | 19.82B |
| Beta Drugs | 18.66B |
| Anlon Healthcare | 14.88B |
| Jagsonpal Pharmaceuticals | 14.53B |